Trial Search Results
Heparin and the Reduction of Thrombosis (HART) Trial
Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units/kg/h) prevent thrombosis, compared to a normal saline infusion, in patients less than one year of age after cardiac surgery?
Stanford is currently not accepting patients for this trial.
- Drug: Heparin sulfate infusion at 10 units/kg/hour
- Drug: Placebo infusion
- All infants < 1 year of age undergoing cardiac surgery at Lucile Packard Children's
Hospital & #xA
- Known coagulopathy
- History of clinically significant bleeding (GI, cranial, pulmonary)
- Need for therapeutic heparinization
Ages Eligible for Study
N/A - 1 Year
Genders Eligible for Study